Bioresorbable vascular scaffolds (BVSs) were designed to overcome the limitations of metallic stents. Absorb BVS has provided information about strut thickness, scaffold degradation, vessel wall coverage, and their influence on thrombosis. Clinical trials have shown higher rates of target vessel myocardial infarction and stent thrombosis with the absorb BVS than with second-generation drug-eluting stents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ccd.28751 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!